Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Nafee

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cardiology Plus|February 2, 2024
State-of-art review: intravascular imaging in percutaneous coronary interventionsTarek Nafee, Areeb Shah, Michael Forsberg, et al.
Progress in Cardiovascular Diseases|January 18, 2018
Anticoagulation in Acute Coronary Syndrome-State of the ArtMichel Zeitouni, Mathieu Kerneis, Tarek Nafee, et al.
Journal of Thrombosis and Thrombolysis|September 20, 2019
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysisWilliam J Gibson, Tarek Nafee, Ryan Travis, et al.
The American Journal of Cardiology|September 16, 2018
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy)Fahad AlKhalfan, Mathieu Kerneis, Tarek Nafee, et al.
The American Journal of Cardiology|January 4, 2020
Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial)Fahad Alkhalfan, Tarek Nafee, Megan K Yee, et al.
International Journal of Clinical Practice|September 7, 2021
Impact of malignancy on In-hospital mortality, stratified by the cause of admission: An analysis of 67 million patients from the National Inpatient SampleOfer Kobo, Sherry-Ann Brown, Tarek Nafee, et al.
Medical Devices (Auckland, N.Z.)|February 6, 2020
The AngelMed Guardian<sup>®</sup> System in the Detection of Coronary Artery Occlusion: Current PerspectivesSyed Hassan Abbas Kazmi, Sudarshana Datta, Gerald Chi, et al.
Progress in Cardiovascular Diseases|February 6, 2018
Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Usama Talib, Tarek Nafee, et al.
Expert Review of Cardiovascular Therapy|March 11, 2017
Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitorsTarek Nafee, Aysha Aslam, Gerald Chi, et al.
Structural Heart : the Journal of the Heart Team|February 28, 2025
Center-Related Variation in Hospitalization Cost for Patients Undergoing Percutaneous Left Atrial Appendage OcclusionShivaraj Patil, Chaitanya Rojulpote, Abhijit Bhattaru, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cardiology Plus|February 2, 2024
State-of-art review: intravascular imaging in percutaneous coronary interventionsTarek Nafee, Areeb Shah, Michael Forsberg, et al.
Progress in Cardiovascular Diseases|January 18, 2018
Anticoagulation in Acute Coronary Syndrome-State of the ArtMichel Zeitouni, Mathieu Kerneis, Tarek Nafee, et al.
Journal of Thrombosis and Thrombolysis|September 20, 2019
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysisWilliam J Gibson, Tarek Nafee, Ryan Travis, et al.
The American Journal of Cardiology|September 16, 2018
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy)Fahad AlKhalfan, Mathieu Kerneis, Tarek Nafee, et al.
The American Journal of Cardiology|January 4, 2020
Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial)Fahad Alkhalfan, Tarek Nafee, Megan K Yee, et al.
International Journal of Clinical Practice|September 7, 2021
Impact of malignancy on In-hospital mortality, stratified by the cause of admission: An analysis of 67 million patients from the National Inpatient SampleOfer Kobo, Sherry-Ann Brown, Tarek Nafee, et al.
Medical Devices (Auckland, N.Z.)|February 6, 2020
The AngelMed Guardian<sup>®</sup> System in the Detection of Coronary Artery Occlusion: Current PerspectivesSyed Hassan Abbas Kazmi, Sudarshana Datta, Gerald Chi, et al.
Progress in Cardiovascular Diseases|February 6, 2018
Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionMathieu Kerneis, Usama Talib, Tarek Nafee, et al.
Expert Review of Cardiovascular Therapy|March 11, 2017
Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitorsTarek Nafee, Aysha Aslam, Gerald Chi, et al.
Structural Heart : the Journal of the Heart Team|February 28, 2025
Center-Related Variation in Hospitalization Cost for Patients Undergoing Percutaneous Left Atrial Appendage OcclusionShivaraj Patil, Chaitanya Rojulpote, Abhijit Bhattaru, et al.
Pageof 3